Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

BUY
$220.09 - $273.15 $336,517 - $417,646
1,529 Added 61.6%
4,011 $895,000
Q4 2023

Feb 26, 2024

BUY
$181.44 - $260.22 $450,334 - $645,866
2,482 New
2,482 $624,000
Q1 2023

May 01, 2023

BUY
$220.43 - $278.69 $339,903 - $429,739
1,542 New
1,542 $429,000
Q3 2021

Nov 12, 2021

SELL
$250.72 - $291.24 $352,010 - $408,900
-1,404 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$235.0 - $310.7 $329,940 - $436,222
1,404 New
1,404 $385,000
Q4 2020

Feb 24, 2021

SELL
$174.98 - $272.83 $1.57 Million - $2.45 Million
-8,969 Closed
0 $0
Q3 2020

Dec 11, 2020

BUY
$185.27 - $238.73 $1.66 Million - $2.14 Million
8,969 New
8,969 $1.74 Million
Q2 2020

Aug 07, 2020

SELL
$153.32 - $191.72 $209,588 - $262,081
-1,367 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$134.81 - $177.8 $184,285 - $243,052
1,367 New
1,367 $225,000
Q3 2019

Nov 20, 2019

SELL
$131.82 - $183.4 $949,499 - $1.32 Million
-7,203 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$124.65 - $167.39 $134,497 - $180,613
1,079 Added 17.62%
7,203 $1.15 Million
Q1 2019

Apr 12, 2019

BUY
$115.84 - $160.31 $709,404 - $981,738
6,124 New
6,124 $901,000
Q4 2018

Jan 16, 2019

SELL
$113.42 - $156.48 $283,209 - $390,730
-2,497 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$121.55 - $156.8 $303,510 - $391,529
2,497 New
2,497 $374,000
Q2 2018

Jul 30, 2018

SELL
$112.2 - $165.95 $882,116 - $1.3 Million
-7,862 Closed
0 $0
Q2 2018

Jul 30, 2018

SELL
$112.2 - $165.95 $131,610 - $194,659
-1,173 Reduced 12.98%
7,862 $1.09 Million
Q1 2018

May 14, 2018

BUY
$84.6 - $126.1 $336,454 - $501,499
3,977 Added 78.63%
9,035 $1.05 Million
Q4 2017

Feb 09, 2018

BUY
$91.55 - $115.85 $241,966 - $306,191
2,643 Added 109.44%
5,058 $476,000
Q3 2017

Nov 20, 2017

BUY
$79.65 - $90.3 $192,354 - $218,074
2,415
2,415 $218,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $11.5B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.